Navigation Links
iLeverage Announces the Successful Sale of the BICO Patent Portfolio for Near-Infrared Non-Invasive Blood Analytes Measurement

SAN FRANCISCO, Dec. 13, 2010 /PRNewswire/ -- iLeverage (, a leading patent broker, today announced the successful closing of the Biocontrol patent portfolio sale.

The patents were offered to companies that participate in the relevant markets as well as to a number of IP licensing companies.  After announcing the auction date on Tuesday Dec. 7, iLeverage received several offers; the most compelling came from the licensing companies.

"We met with leaders of the medical monitoring market in the USA and in Europe with the hope that an operating company would acquire the patents, however due to the wide coverage of this portfolio and its relatedness to so many different companies, the patents were given the highest values by licensing companies – a natural result from an economic standpoint," said Uzi Aloush, iLeverage's CEO. For more information, please see


SOURCE iLeverage
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Stryker Announces Election of New Director
2. Hanger Orthopedic Group, Inc. Announces Pricing of Underwritten Public Offering by Shareholder
3. HeartWare International, Inc. Announces Pricing of Concurrent Public Offerings of Convertible Senior Notes and Common Stock
4. MTEC Announces Release of NexGen Speech Recognition Editing and Medical Transcription Training Program
5. Physiotherapy Associates Announces New Multiple Sclerosis Specialty Treatment Program
6. Anthera Announces Update Call Regarding Vial Problems
7. HeartWare International, Inc. Announces Concurrent Public Offerings of Convertible Senior Notes and Common Stock
8. NeoStem Announces Agreement With Shijiazhuang Third Hospital in the Provincial Capital of Hebei Province, China to Offer Orthopedic Applications Based on NeoStem’s Licensed Technology
9. Lotus Pharmaceuticals Announces Update on Land in Inner Mongolia
10. Bioheart Announces Plans to Advance LVAD + Muscle Stem Cells Clinical Trial
11. Stryker Announces Additional $500 Million Share Repurchase Program and Declares a 20% Increase in Quarterly Dividend
Post Your Comments:
(Date:6/23/2016)... , June 23, 2016  MedSource announced today ... its e-clinical software solution of choice.  This latest ... possible value to their clients by offering a ... preferred relationship establishes nowEDC as the EDC platform ... MedSource,s full-service clients.  "nowEDC has long been a ...
(Date:6/23/2016)... 23, 2016  In a startling report released today, National ... by lacking a comprehensive, proven plan to eliminate prescription opioid overdoses. ... of how states are tackling the worst drug crisis in recorded ... – Kentucky , New Mexico ... . Of the 28 failing states, three – Michigan ...
(Date:6/23/2016)... Research and Markets has announced the addition of ... their offering. The current ... environment for MedImmune to enter. The US ageing population creates ... drive considerable growth for effective anti-influenza medications. The introduction of ... but development is still in its infancy. ...
Breaking Medicine Technology:
(Date:6/27/2016)... Brooklyn, NY (PRWEB) , ... June 27, 2016 ... ... is using cutting edge technology to revolutionize the emergency ambulance transport experience for ... Many are aware of how Uber has disrupted the taxi industry through the ...
(Date:6/26/2016)... ... June 26, 2016 , ... On June 10-11, 2016, A ... 2016 Cereal Festival and World’s Longest Breakfast Table in Battle Creek, MI, where the ... history as home to some of the world’s leading providers of cereal and other ...
(Date:6/26/2016)... ... June 26, 2016 , ... Brent Kasmer, a legally blind and certified personal trainer is ... a fitness app. The fitness app plans to fix the two major problems leading the ... one size fits all type program , They don’t eliminate all the reasons ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... Austin residents ... the American College of Mohs Surgery and to Dr. Russell Peckham for medical and ... highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed ...
(Date:6/25/2016)... , ... June 25, 2016 , ... First Choice ... States, named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm ... Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical ...
Breaking Medicine News(10 mins):